NNVC - NanoViricides, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NNVC - NanoViricides, Inc.

NNVC 1.230

-2.0%

10:14 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: old 'n cranky	1/4/2020 8:34:11 AM
	Read Replies (1) of 12873

From the TheraCour Waiver Letter Regarding Conversion of Series A Shares: 2. Waiver. Holder hereby agrees to waive any and all conversion rights in the Designation until the earlier of: (a) December 31, 2019, or (b) the date the Company amends its Articles of incorporation to increase its authorized number of shares of Common Stock to not less than 150,000,000 shares (the “Authorized Increase”). 3. Company Covenants, Representations and Warranties.d. In the event that the Company does not increase its authorized number of shares of Common Stock to not less than 150,000,000 shares (the “Authorized Increase”) on or before December 31, 2019, without limitation of any other remedies available to Holder, the Company shall if requested by Holder negotiate promptly and in good faith with the Holder to replace the Series A certificates with instruments of at least equal value, such value to be estimated as though there was no waiver in effect and as though the Company had performed the Authorized Increase. sec.gov

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next